BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 7953023)

  • 21. Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment.
    Arndt S; Tyrrell G; Flaum M; Andreasen NC
    Psychol Med; 1992 May; 22(2):379-88. PubMed ID: 1615105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comorbidity of schizophrenia and substance abuse: implications for treatment.
    Mueser KT; Bellack AS; Blanchard JJ
    J Consult Clin Psychol; 1992 Dec; 60(6):845-56. PubMed ID: 1460148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of alcohol and other drug disorders in the seriously mentally ill.
    Barry KL; Fleming MF; Greenley J; Widlak P; Kropp S; McKee D
    Schizophr Bull; 1995; 21(2):313-21. PubMed ID: 7631177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug abuse in schizophrenia: comparison of patients who began drug abuse before their first admission with those who began abusing drugs after their first admission.
    Silver H; Abboud E
    Schizophr Res; 1994 Aug; 13(1):57-63. PubMed ID: 7947416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrating substance abuse treatment for the seriously mentally ill into inpatient psychiatric treatment.
    Bradizza CM; Stasiewicz PR
    J Subst Abuse Treat; 1997; 14(2):103-11. PubMed ID: 9258854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia.
    Joyal CC; Hallé P; Lapierre D; Hodgins S
    Schizophr Res; 2003 Oct; 63(3):297-9. PubMed ID: 12957709
    [No Abstract]   [Full Text] [Related]  

  • 27. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
    Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
    Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term course of substance use disorders among patients with severe mental illness.
    Bartels SJ; Drake RE; Wallach MA
    Psychiatr Serv; 1995 Mar; 46(3):248-51. PubMed ID: 7796211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substance abuse as a risk factor for violence in major mental disorders.
    Soyka M
    Arch Gen Psychiatry; 1999 Jun; 56(6):582. PubMed ID: 10359476
    [No Abstract]   [Full Text] [Related]  

  • 30. Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder.
    Sevy S; Robinson DG; Holloway S; Alvir JM; Woerner MG; Bilder R; Goldman R; Lieberman J; Kane J
    Acta Psychiatr Scand; 2001 Nov; 104(5):367-74. PubMed ID: 11722318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Consumption patterns and motivation for use of addictive drugs in schizophrenic patients].
    Lambert M; Haasen C; Mass R; Krausz M
    Psychiatr Prax; 1997 Jul; 24(4):185-9. PubMed ID: 9340658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychiatric comorbidity in forensic psychiatry.
    Palijan TZ; Muzinić L; Radeljak S
    Psychiatr Danub; 2009 Sep; 21(3):429-36. PubMed ID: 19794370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings.
    Thoma P; Daum I
    Psychiatry Clin Neurosci; 2013 Sep; 67(6):367-83. PubMed ID: 23890122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Alcohol and drug abuse as risk factors for violence and delinquency in schizophrenic patients].
    Soyka M; Immler B; Sand P
    Psychiatr Prax; 1993 Sep; 20(5):172-5. PubMed ID: 8248441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substance use: a powerful predictor of relapse in schizophrenia.
    Swofford CD; Kasckow JW; Scheller-Gilkey G; Inderbitzin LB
    Schizophr Res; 1996 May; 20(1-2):145-151. PubMed ID: 8794502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [History of treatment of schizophrenic forensic patients prior to admission: a comparison with schizophrenic general psychiatric patients].
    Piontek K; Kutscher SU; König A; Leygraf N
    Nervenarzt; 2013 Jan; 84(1):55-64. PubMed ID: 22215217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug abuse: a significant variable in schizophrenia research.
    Boutros N; Bonnet K; Mak T
    Biol Psychiatry; 1996 Jun; 39(12):1053-4. PubMed ID: 8780842
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparative study on schizophrenic patients with dual diagnosis.
    Modestin J; Gladen CJ; Christen S
    J Addict Dis; 2001; 20(4):41-51. PubMed ID: 11760925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reasons for substance use in schizophrenia.
    Addington J; Duchak V
    Acta Psychiatr Scand; 1997 Nov; 96(5):329-33. PubMed ID: 9395149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.